Phase II Trial of Chemotherapy with Docetaxel plus Cisplatin for Patients with Recurrent or Metastatic Non-squamous Cell Carcinoma of Head and Neck
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Jan 2017
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- Acronyms HN non-SCC P2 DC
- 05 Jan 2017 Planned End Date changed from 1 Sep 2015 to 1 Nov 2017.
- 05 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 04 Sep 2012 New trial record